Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
| 19.02 Delayed Data As of Jan 21 |  -1.91 / -9.13%Today’s Change | 13.83 Today|||52-Week Range 28.95 | -33.05% Year-to-Date |
Latest CRNX News | Press Releases
No recent news for Crinetics Pharmaceuticals Inc.
Today’s Trading
| Previous close | 20.93 |
| Today’s open | 20.62 |
| Day’s range | 18.97 - 20.63 |
| Volume | 13,309 |
| Average volume (3 months) | 289,457 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -16.23% |
| Earnings growth (this year) | -12.63% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZEALZealand Pharma A/S | -0.79 | -3.82% |
| ---- | ||
| MNKDMannKind Corp | -0.13 | -3.31% |
| RETAReata Pharmaceutical... | -1.03 | -3.78% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | March 15, 2022 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$73.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
